Prof. YILDIZ ERGİNER

Metrics

Publication

221

Publication (WoS)

Publication (Scopus)

Citation (WoS)

511

H-Index (WoS)

Citation (Scopus)

725

H-Index (Scopus)

Citation (Scholar)

451

H-Index (Scholar)

Citation (TrDizin)

H-Index (TrDizin)

Citation (Sum Other)

Project

115

Intellectual Property

Thesis Advisory

Open Access

UN Sustainable Development Goals

Announcements & Documents

Lecture Note

Ruhsat Tanımlar

Lecture Note

1/9/2020

TANIMLAR.pdf

Tıbbi Cihaz

Lecture Note

1/9/2020

MEDİKAL BİYOMEDİKAL CİHAZ VE ÜRÜNLE....pdf

Farm Tekn II

Lecture Note

5/8/2018

ENJEKSIYONLUK PREP 2018.pdf

Farmasötik Biyoteknoloji Dersi-2

Lecture Note

5/8/2018

Biyoteknolojik+Ürün+Hazırlama.pdf

Farmasötik Biyoteknoloji Dersi-1

Lecture Note

5/8/2018

Farmasötik+Biyoteknoloji+Giris.pdf

SOP Örneği

Lecture Note

5/8/2018

SOP+ORNEGI.pdf

Talimat Örneği

Lecture Note

5/7/2018

Talimat Ornegi.pdf

Enjeksiyonluk Preparatlar 2018

Lecture Note

5/7/2018

ENJEKSIYONLUK PREP 2018.pdf

Farmasötik Biyoteknoloji Dersi

Lecture Note

5/2/2018

Biyoteknolojik Ürün Hazırlama.pdf

Farmasötik Biyoteknoloji Dersi

Lecture Note

5/2/2018

Farmasötik Biyoteknoloji Giris.pdf

GMP 2018

Lecture Note

4/19/2018

GMP fakulte.pdf

VALİDASYON 2018

Lecture Note

4/19/2018

validasyon.pdf

Farm Tekn II-Ölçek Büyütme

Lecture Note

3/13/2018

Ölçek Büyütme (Scale-up).pdf

Farm Tekn II-Enjeksiyonluk Preparatlar 2018

Lecture Note

3/13/2018

ENJEKSIYONLUK PREP 2018 .pdf

Farm Tekn II-Hesaplamalar 2018

Lecture Note

3/13/2018

HESAPLAMALAR 2018.pdf

İlaç Müh-Emülsiyon- Süspansiyon üretim

Lecture Note

3/13/2018

EMULSIYON VE SUSPANSIYON.pdf

İlaç Müh- Göz Merhemi üretimi

Lecture Note

3/13/2018

GÖZ MERHEMİ ÜRETİMİ.pdf

İlaç Müh-Krem üretimi

Lecture Note

3/13/2018

KREM ÜRETİMİ.pdf

ilaç Müh-Şurup üretimi

Lecture Note

3/13/2018

ŞURUP ÜRETİMİ.pdf

Ruhsat-Modül 3

Lecture Note

12/19/2017

MODÜL 3 farm gelişim.pdf

Patent çeşitleri

Lecture Note

12/19/2017

PATENT CESITLERI.pdf

Patent-farmasötik patent çeşitleri

Lecture Note

12/19/2017

Farmasötik patent çeşitleri .pdf

Ruhsat-Ölçek büyütme

Lecture Note

12/19/2017

Ölçek Büyütme (Scale-up).pdf

Ruhsat-Stabilite

Lecture Note

12/19/2017

stabilite TITCK 2017.pdf

Ruhsat-Talimat örneği

Lecture Note

12/19/2017

Talimat örnegi.pdf

Ruhsat-Sop Örneği

Lecture Note

12/19/2017

SOP ORNEGI.pdf

Ruhsat-Farmasötik Gelişim

Lecture Note

12/19/2017

FARMASOTİK_GELISIM.pdf

Vajinal ve Rektal sistemler

Lecture Note

12/18/2017

VAJINAL ve REKTAL SISTEMLER.pdf

Nano taşıyıcılı sistemler

Lecture Note

12/18/2017

NANO TAŞIYICILLI SİSTEMLER.pdf

Kolona ilaç taşıyan sistemler

Lecture Note

12/18/2017

KOLONA ilaç taşıyan sistemler.pdf

Patent Farm.Tekn III

Lecture Note

12/18/2017

PATENT DERSI F.TEKN III.pdf

Transdermal sistemler

Lecture Note

12/18/2017

TRANSDERMAL SİSTEMLER.pdf

Oral sistemler

Lecture Note

12/18/2017

ORAL SİSTEMLER.pdf

Oküler sistemler

Lecture Note

12/18/2017

OKÜLER SİSTEMLER.pdf

nazal sistemler

Lecture Note

12/18/2017

NAZAL SISTEMLER.pdf

mukozaya yapışan sistemler

Lecture Note

12/18/2017

MUKOZAYA YAPIŞAN SİSTEMLER.pdf

İlaçta Patent Seçimlik Dersi

Lecture Note

11/2/2017

Ders sunumu

Arge ve inovasyon.pdf

ilaçların Ruhsatlandırılması

Lecture Note

11/2/2017

Ders sunumu

RUHSAT_MODÜL 1.pdf

İlaçların Ruhsatlandırılması

Lecture Note

11/2/2017

Ders sunumu

RUHSAT_TANIMLAR.pdf

İlaçta Patent Seçimlik Dersi

Lecture Note

11/2/2017

Ders sunumu

PATENTİN KORUMA KAPSAMI.pdf

İlaçta Patent Seçimlik Dersi

Lecture Note

11/2/2017

Ders sunumu

İnternette Patent Taraması.pdf

İlaçta Patent Seçimlik Dersi

Lecture Note

11/2/2017

Lisans Dersi sunumları ektedir.

PATENT DERSİ_ANLASMALAR.pdf

Education

1985 - 1989

Doctorate

Istanbul University, Faculty of Pharmacy , Farmasötik Teknoloji Anabilim Dalı, Turkey

1982 - 1985

Postgraduate

Istanbul University, Faculty of Pharmacy , Farmasötik Teknoloji Anabilim Dalı, Turkey

1978 - 1982

Undergraduate

Istanbul University, Faculty of Pharmacy , Farmasötik Teknoloji Anabilim Dalı, Turkey

Dissertations

1989

Doctorate

HEPARİN ÜZERİNE ÇALIŞMALAR

Istanbul University, Faculty of Pharmacy , Farmasötik Teknoloji

1985

Postgraduate

ASPİRİN, NOVALJİN, KAFEİN TABLETLERİ HAZIRLANMASI ÜZERİNE ÇALIŞMALAR

Istanbul University, Faculty of Pharmacy , Farmasötik Teknoloji

Foreign Languages

B2 Upper Intermediate

English

Research Areas

Health Sciences

Pharmacology and Therapeutics

Pharmaceutics Technology

Pharmaceutical Biotechnology

Pharmaceutical Technology

Biopharmaceutical and Pharmacokinetics

Radiopharmacy

Research Areas Based on Academic Activities

Avesis Research Areas

WoS Research Areas

Scopus Research Areas

Academic Positions

2006 - Present

Professor

Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology

2000 - 2006

Associate Professor

Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology

1993 - 2000

Assistant Professor

Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology

Managerial Experience

2020 - Present

Rectorate Commissioner

Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology

2020 - Present

Head of Department

Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology

2020 - Present

Member of the Faculty Board

Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology

2005 - 2013

Vice Dean

İstanbul Üniversitesi, Faculty of Pharmacy , Eczacılık Teknolojisi

1994 - 2006

Board Member

İstanbul Üniversitesi, Faculty of Pharmacy , Eczacılık Teknolojisi

Non Academic Experience

2002 - 2002

yurt dışı araştırma

The School of Pharmacy-London-UK, yurt dışı araştırma

1997 - 1997

yurt dışı araştırma

Aston Üniversitesi-Birmingam-UK, yurt dışı araştırma

1995 - 1995

yurt dışı araştırma

Aston Üniversitesi-Birmingam-UK, yurt dışı araştırma

Courses

Doctorate

İLAÇ PATENTLERİNİNİ AR-GE ÇALIŞMALARI ÇERÇEVESİNDE YORUMLANMASI

İLERİ ENDÜSTRİYEL ÜRETİM

FORMÜLASYON

Postgraduate

ENDÜSTRİYEL ÜRETİMİN TEMELLERİ

ÖNFORMÜLASYON

NAZAL İLAÇ TAŞIYICI SİSTEMLER

Undergraduate

FARMASÖTİK TEKNOLOJİ II

İlaç Mühendisliği

Farmasötik Biyoteknoloji

NANOFARMASÖTİKLER

İLAÇTA PATENT

İLAÇLARIN RUHSATLANDIRILMASI

Supervised Theses

2021

Doctorate

Çözünürlüğü düşük etken maddenin kendiliğinden emülsifiye olan yeni formülasyonlarının geliştirilmesi ve in vitro karakterizasyon çalışmaları

Erginer Y. (Advisor)

H.NAZLI(Student)

2021

Doctorate

Göze Ugulanmak Üzere İlaç Taşıyıcı Sistemlerin Tasarımı Hakkında Çalışmalar

Erginer Y. (Advisor)

B.ÜNER(Student)

2019

Doctorate

Hipertrofik skar tedavisi için topikal formülasyonların tasarlanması

Erginer Y. (Co-Advisor), Özer K. Ö.

A.ASRAM(Student)

2019

Doctorate

Oküler Uygulamaya Yönelik Nanotaşıyıcıların Hazırlanması

Erginer Y. (Advisor)

M.Ezgi(Student)

2017

Doctorate

Ölçek Büyütmeye Uygun Nanoemülsiyon Formülasyonunun QbD ile Tasarımı ve Yapay Sinir Ağları ile Optimizasyonu

Erginer Y. (Advisor)

B.MESUT(Student)

2017

Doctorate

pankreas kanseri tedavisine yönelik gemsitabin ve vismodegib içeren misellerin hazırlanması ve karakterizasyonu

Erginer Y. (Advisor)

M.KARACA(Student)

2017

Postgraduate

Repaglinid ve metformin içeren tablet formülasyonlarının hazırlanması ve in vitro değerlendirilmesi

Erginer Y. (Advisor)

S.ŞAHİN(Student)

2017

Doctorate

Topikal uygulamaya yönelik polimerik misel sistemlerinin geliştirilmesi

Erginer Y. (Advisor)

E.KAHRAMAN(Student)

2016

Doctorate

Enzim Kontrollü Uzatılmış Salımlı Tablet Formülasyonunun Hazırlanması ve Optimizasyonu

Erginer Y. (Advisor)

E.Ayçiçek(Student)

2014

Postgraduate

Alfuzosin hidroklorür içeren ağızda dağılan tabletlerin tasarımda kalite (QbD) çerçevesinde risk değerlendirmesi ile formülasyon tasarımı

Erginer Y. (Advisor)

G.GÜNCAN(Student)

2014

Doctorate

Ketiapin fumarat etkin maddesini içeren uzatılmış salımlı tablet formülasyonlarının yapay sinir ağları ile tasarımı

Erginer Y. (Advisor)

E.Özçelik(Student)

2011

Postgraduate

Ondansetron hidroklorürün topikal formülasyonlarının geliştirilmesi ve perkütan absorpsiyonlarının incelenmesi

Erginer Y. (Advisor)

A.Sedef(Student)

2011

Postgraduate

Nöro-bulanık mantık yardımı ile Alfuzosin HCl içeren tablet formülasyonlarının tasarım çalışması

ERGİNER Y.

B.Mesut(Student)

2011

Postgraduate

Misel Oluşturan, Biyobozunur, Biyouyumlu, Katyonik Polimerler ile İlaçların Nazal Yol ile Uygulanması

ERGİNER Y.

E.Kahraman(Student)

2009

Postgraduate

Metoklopramid HCl’in in vitro penetrasyonunun terpenler kullanılarak arttırılması üzerine çalışmalar

ERGİNER Y.

B.Aktar(Student)

2009

Postgraduate

Verapamil HCl in nazal dozaj formları üzerine çalışmalar

ERGİNER Y.

Ö.Yenil(Student)

2005

Postgraduate

Nifedipin’in doğal polimerler ile transdermal formülasyonlarının hazırlanması üzerine çalışmalar

ERGİNER Y.

A.Bektaş(Student)

2003

Postgraduate

Siprofloksazin’in Kitozan ile mikro- ve nanopartiküllerinin hazırlanması ve nazal olarak uygulanması üzerine çalışmalar

ERGİNER Y.

D.Gürcan(Student)

Articles

2026

1. A quality by design study of the use of microfluidic nanoprecipitation for the generation of sub-100 nm drug nanocrystals

Pirincci Tok Y., Abukhamees S., Fitaihi R., Demiralp B., Ozsoy Y., Craig D. Q. M.

COLLOIDS AND SURFACES B-BIOINTERFACES , vol.262, 2026 (SCI-Expanded, Scopus)

2026

2. Carbon dots in nasal delivery: Emerging strategies for enhanced therapeutic efficacy

Kaid N., Camlik G., Ozsoy Y.

Journal of Drug Delivery Science and Technology , vol.117, 2026 (SCI-Expanded, Scopus)

2026

3. Development of Brimonidine-Loaded Ethosomes for Glaucoma: Investigation of Intraocular Pressure-Lowering Potential In Vivo

Erginer Y.

PHARMACEUTICS , vol.18, no.210, pp.1-26, 2026 (Peer-Reviewed Journal)

2026

4. Influence of Drying Methods on Redispersibility and Dissolution of Canagliflozin Nanocrystals: A Comparative Approach

Erginer Y.

Pharmaceuticals , vol.19, no.240, pp.1-26, 2026 (Peer-Reviewed Journal)

2025

5. Innovative Formulation Approaches and Administration Routes of Lurasidone HCl for the Treatment of Schizophrenia and Bipolar Disorder: Traditional Review

Kazaz M. Ç., Erginer Y.

J Lit Pharm Sci , vol.14, no.3, pp.105-114, 2025 (TRDizin)

2025

6. Preparation and in vitro Characterisation of Nanofibers for Enhancing the Water Solubility of Poorly Soluble Drugs

Erginer Y.

İstanbul Journal of Pharmacy , vol.55, no.3, pp.318-331, 2025 (TRDizin)

2025

7. Cochleate Novel Drug Delivery System

Erdoğan Ü., Erginer Y.

İstanbul Journal of Pharmacy , vol.55, no.3, pp.1-9, 2025 (TRDizin)

2025

8. In Vitro Antimicrobial Activity and In Vivo Effectiveness of the Cosmetic Products Developed for Oily Skin

ERDAL M. S., Aydilek N., GÜNGÖR S., DÖŞLER S., OYARDI Ö., Alici M., et al.

ISTANBUL JOURNAL OF PHARMACY , vol.55, no.2, pp.160-172, 2025 (ESCI, TRDizin)

2025

9. The lenalidomide derivative loaded and quercetin modified MIL-100 based novel drug delivery system for breast cancer treatment

Özsoy M., Tok Y. P., Eskiler G. G., TOK F., Karakus S., Ozsoy Y., et al.

Journal of Drug Delivery Science and Technology , vol.108, 2025 (SCI-Expanded)

2025

10. Phytoactive Molecules and Nanodelivery Approaches for Breast Cancer Treatment: Current and Future Perspectives

ALĞIN YAPAR E., ÖZDEMİR M. N., Cavalu S., AKBAL DAĞISTAN Ö., Ozsoy Y., KARTAL M.

Current Pharmaceutical Biotechnology , vol.26, no.6, pp.795-812, 2025 (SCI-Expanded)

2025

11. Nanodelivery Approaches of Phytoactives for Skin Cancers: Current and Future Perspectives

Yapar E. A., Özdemir M. N., Durgun M. E., Dağıstan Ö., Cavalu S., Özsoy Y., et al.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY , vol.26, no.5, pp.631-653, 2025 (SCI-Expanded, Scopus)

2024

12. Vesicular Drug Delivery Systems: Promising Approaches in Ocular Drug Delivery

Batur E., Özdemir S., Durgun M. E., Özsoy Y.

Pharmaceuticals , vol.17, no.4, 2024 (SCI-Expanded)

2024

13. A new approach for the treatment of Alzheimer’s disease: insulin-quantum dots

Camlik G., Bilakaya B., Ozsoy Y., Degim I. T.

Journal of Microencapsulation , vol.41, no.1, pp.18-26, 2024 (SCI-Expanded)

2024

14. An Overview of Wearable Medical Device Applications

ÇELİK Y. S., İlçe E., MESUT B., Özsoy Y.

Journal of Research in Pharmacy , vol.28, no.3, pp.722-732, 2024 (ESCI, Scopus, TRDizin)

2024

15. CYTOTOXIC ACTIVITY AND EVALUATION OF IN VITRO RELEASE OF APIGENIN 7-O-GLUCOSIDE FROM THE TOPICAL PHARMACEUTICAL FORMULATION CONTAINING MATRICARIA RECUTITA L. FLOWER EXTRACT

Cicek M., Aydilek N., ULUSOY Ş., İNAL E., Inan H. A., DAĞ A., et al.

Acta Poloniae Pharmaceutica - Drug Research , vol.81, no.3, pp.483-501, 2024 (SCI-Expanded)

2023

16. Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus

Özkan B., ALTUNTAŞ E., Ünlü Ü., Doğan H. H., Özsoy Y., ÇAKIR KOÇ R.

Pharmaceutics , vol.15, no.8, 2023 (SCI-Expanded)

2023

17. Polymeric-Micelle-Based Delivery Systems for Nucleic Acids

Sinani G., Durgun M. E., CEVHER E., Özsoy Y.

Pharmaceutics , vol.15, no.8, 2023 (SCI-Expanded)

2023

18. Systematic Screening Study for the Selection of Proper Stabilizers to Produce Physically Stable Canagliflozin Nanosuspension by Wet Milling Method

Pirincci Tok Y., MESUT B., GÜNGÖR S., Sarıkaya A. O., Aldeniz E. E., Dude U., et al.

Bioengineering , vol.10, no.8, 2023 (SCI-Expanded, Scopus)

2023

19. Biopolymer-Based Nanogel Approach in Drug Delivery: Basic Concept and Current Developments

Altuntas E., özkan b., Güngör S., OZSOY Y.

PHARMACEUTICS , vol.15, no.6, pp.1644, 2023 (SCI-Expanded)

2023

20. A Novel Semi-Solid Self-Emulsifying Formulation of Aprepitant for Oral Delivery: An In Vitro Evaluation

Nazlı H., MESUT B., AKBAL DAĞISTAN Ö., Özsoy Y.

Pharmaceutics , vol.15, no.5, 2023 (SCI-Expanded, Scopus)

2023

21. In-vivo evaluation of an innovative feed additive formulation of Pinus Brutia ten. resin containing turpentine and colophony and the effects on milk production performance and somatic cell counts of Holstein dairy cows

Tekdemir O., Özçelik E., Akbaş I., Erginer Y.

Journal of Istanbul Veterinary Science , vol.7, no.1, pp.1-7, 2023 (Peer-Reviewed Journal)

2023

22. Nanofibers in Ocular Drug Targeting and Tissue Engineering: Their Importance, Advantages, Advances, and Future Perspectives

Uzel E., Durgun M. E., Esentürk-Güzel İ., GÜNGÖR S., Özsoy Y.

Pharmaceutics , vol.15, no.4, 2023 (SCI-Expanded)

2023

23. Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory Activity.

Uner B., Ozdemir S., Tas C., Uner M., Ozsoy Y.

AAPS PharmSciTech , vol.24, no.4, pp.92, 2023 (SCI-Expanded)

2023

24. Effect of Mannitol Particle Size on Melatonin Dissolution and Tablet Properties using a Quality by Design Framework

DEMİRALP B., Tok Y. P., Alkan B., Vefai M. K., Al-Mohaya M., ERGİNER Y.

DISSOLUTION TECHNOLOGIES , vol.30, no.1, pp.12-21, 2023 (SCI-Expanded, Scopus)

2023

25. Evaluation of Critical Quality Attributes of Dapsone Gel

Kalami E., Kahraman E., Dedeoğlu E., Gürbüz K., Özsoy Y., GÜNGÖR S.

Dissolution Technologies , vol.30, no.1, pp.30-35, 2023 (SCI-Expanded)

2023

26. Nasal in situ gels as a drug delivery system: An overview of literature and clinical studies

ÇELİK Y. S., Örenli B., Al-Mohaya M., MESUT B., Özsoy Y.

Journal of Research in Pharmacy , vol.27, no.5, pp.1875-1888, 2023 (ESCI, Scopus, TRDizin)

2023

27. Preparation, optimization, and In vitro drug release study of microemulsions of posaconazole

Sanaei Oskouei S., ARAMAN A. O., Erginer Y.

Journal of Drug Delivery Science and Technology , vol.79, 2023 (SCI-Expanded)

2022

28. A smarter, tactical approach for combating Covid-19

Çamlık G., Erginer Y., Değim İ. T.

Istanbul Journal of Pharmacy , vol.52, no.3 , pp.357-361, 2022 (Peer-Reviewed Journal)

2022

29. Development of lipid nanoparticles for transdermal loteprednol etabonate delivery

Uner B., Ozdemir S., Tas C., ERGİNER Y., Uner M.

JOURNAL OF MICROENCAPSULATION , vol.39, no.4, pp.327-340, 2022 (SCI-Expanded)

2022

30. Posaconazole micelles for ocular delivery: in vitro permeation, ocular irritation and antifungal activity studies

Durgun M. E., Kahraman E., Hacioglu M., Gungor S., Ozsoy Y.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH , vol.12, no.3, pp.662-675, 2022 (SCI-Expanded)

2022

31. RECENT TECHNOLOGIES IN CONTROLLED RELEASE DRUG DELIVERY

Özçelik E., Erdal M. S., Özsoy Y.

Sabiad , vol.5, no.2, pp.122-129, 2022 (Peer-Reviewed Journal)

2022

32. Nanocrystal Technology: Increasing Oral Bioavailability of Low-Soluble Drugs

Erginer Y., Pirinçci Tok Y., Güngör S.

Istanbul University Institute of Health Sciences Journal of Advanced Research in Health Sciences , vol.5, no.1, pp.1-12, 2022 (Peer-Reviewed Journal)

2021

33. Estimating the Optimal Dexketoprofen Pharmaceutical Formulation with Machine Learning Methods and Statistical Approaches

Baskor A., Tok Y. P., Mesut B., Ozsoy Y., Ucar T.

HEALTHCARE INFORMATICS RESEARCH , vol.27, no.4, pp.279-286, 2021 (ESCI, Scopus)

2021

34. Examining the basic principles of quality by design (QbD) approach in analytical studies

MESUT B., Onal C., Aksu B., ERGİNER Y.

ISTANBUL JOURNAL OF PHARMACY , vol.51, no.2, pp.271-276, 2021 (ESCI)

2021

35. A Review On Current Perspective Of Gastroretentive Drug Delivery Systems Prioritising Floating Dosage Forms

Başarır N. S., Mesut B., Erginer Y.

Sağlık Bilimlerinde İleri Araştırmalar Dergisi , vol.4, no.2, pp.43-64, 2021 (Peer-Reviewed Journal)

2021

36. Çözünürlüğü Düşük Olan Etken Maddeler İçin Farmasötik Yaklaşımlar ve Aprepitantın Çözünürlüğü

Erginer Y., Nazlı H., Mesut B.

FABAD J. Pharm. Sci. , vol.46, no.3, pp.325-344, 2021 (TRDizin)

2021

37. Preparation and in vitro studies of fixed-dose tablet combination of repaglinide and metformin

Sahin S., MESUT B., Durgun M. E., Ozcelik E., ERGİNER Y.

ISTANBUL JOURNAL OF PHARMACY , vol.51, no.1, pp.26-34, 2021 (ESCI)

2021

38. Ozmotik Kontrollü İlaç Salım Sistemleri

Erginer Y., Pelen B., Özçelik E.

Journal of Literature Pharmacy Sciences , vol.10, no.1, pp.51-64, 2021 (Peer-Reviewed Journal)

2021

39. Formulation development and evaluation of taste-masked atomoxetine hydrochloride orally disintegrating tablets (Odts)

Kazaz Ç., Mesut B., Özsoy Y., Ocak E. M.

Journal of Research in Pharmacy , vol.25, no.5, pp.715-727, 2021 (ESCI, Scopus, TRDizin)

2021

40. Developing, optimization and in vitro evaluating of three-layers floating dipyridamole film in hard gelatine capsule

Ozcelik E., Sagıroglu A. A., Ozsoy Y.

Acta Pharmaceutica Sciencia , vol.59, no.2, pp.253-273, 2021 (Scopus)

2021

41. Stability indicating method development and validation of ranolazine extended release tablets

Durak E. A., Kurtgöz İ., MESUT B., CEVHER E., Özsoy Y.

Acta Pharmaceutica Sciencia , vol.59, no.3, pp.419-434, 2021 (Scopus)

2020

42. Design, optimization and characterization of novel topical formulations containing Triamcinolone Acetonide

Sagiroglu A. A., Ozsoy Y., Ozer O.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.58, 2020 (SCI-Expanded)

2020

43. Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.

Durgun M., Güngör S., Özsoy Y.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics , vol.36, pp.323-341, 2020 (SCI-Expanded)

2020

44. Veteriner Alanda Kullanılan Modifiye Salımlı Dozaj Şekilleri

Erginer Y.

Türk Farmakope Dergisi , vol.5, no.2, pp.25-36, 2020 (Peer-Reviewed Journal)

2020

45. Optimization and Characterization of Aqueous Micellar Formulations for Ocular Delivery of an Antifungal Drug, Posaconazole

Durgun M., Kahraman E., Güngör S., Özsoy Y.

CURRENT PHARMACEUTICAL DESIGN , vol.26, no.14, pp.1543-1555, 2020 (SCI-Expanded)

2020

46. In vitro skin permeation and antifungal activity of naftifine microemulsions Naftifin mikroemülsiyonlarının in vitro deriden permeasyonu ve antifungal aktivitesi

Erdal M. S., Gürbüz A., Birteksöz T., Güngör S., Özsoy Y.

Turkish Journal of Pharmaceutical Sciences , vol.17, no.1, pp.43-48, 2020 (ESCI, Scopus, TRDizin)

2019

47. Product transfer from lab-scale to pilot-scale of quetiapine fumarate orodispersible films using quality by design approach

Bulbul E. O., Mesut B., Cevher E., Oztas E., Ozsoy Y.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.54, 2019 (SCI-Expanded, Scopus)

2019

48. Yeni Dozaj Formları:Oral Filmler

Özcan Bülbül E., YILDIZ PEKÖZ A., ERGİNER Y.

Literatür Eczacılık Bilimleri , vol.1, pp.1-14, 2019 (Peer-Reviewed Journal)

2019

49. Formulation design and taste assessment in orally disintegrating tablets

KAZAZ Ç., OCAK DEMİRCİ E. M., MESUT B., ERGİNER Y.

FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , vol.44, no.2, pp.169-178, 2019 (Scopus)

2017

50. Quetiapine Fumarate Extended-release Tablet Formulation Design Using Artificial Neural Networks

Ozcelik E., Mesut B., Aksu B., Ozsoy Y.

TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.14, no.3, pp.213-221, 2017 (ESCI, Scopus, TRDizin)

2017

51. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery

Kahraman E., Gungor S., Ozsoy Y.

THERAPEUTIC DELIVERY , vol.8, no.11, pp.967-985, 2017 (ESCI)

2017

52. BUDESONIDE SELF-NANOEMULSION FORMULATION AS AN ORAL DRUG DELIVERY SYSTEM: PREPARATION, CHARACTERIZATION AND CYTOTOXICITY STUDIES

Mesut B., Tekarslan Şahin Ş. H., Erginer Y.

PressAcademia Procedia , vol.5, no.1, pp.41-46, 2017 (Peer-Reviewed Journal)

2017

53. Inhaled Heparin: Therapeutic Efficacy and Recent Formulations

Yildiz-Pekoz A., Ozsoy Y.

JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY , vol.30, no.3, pp.143-156, 2017 (SCI-Expanded)

2017

54. Formulation Design of the Oral Disintegrating Tablets Including Alfuzosin Hydrochloride with Risk Evaluation via Quality by Design

GÜNCAN G., ERGİNER Y., Aksu B., MESUT B., Yeğen G.

Acta Pharm. Sci. , vol.55, no.2, pp.57-76, 2017 (Peer-Reviewed Journal)

2017

55. Targeted drug delivery and vaccinology approaches using virus-like particles for cancer

Sereflioglu S., Yapici E., Sahin S. H. T., Ozsoy Y., ÜSTÜNDAĞ C. B.

ISTANBUL JOURNAL OF PHARMACY , vol.47, no.3, pp.112-119, 2017 (ESCI)

2017

56. Advances in Micelle-based Drug Delivery: Cross-linked Systems

İŞOĞLU İ. A., Ozsoy Y., DİNÇER İŞOĞLU S.

CURRENT TOPICS IN MEDICINAL CHEMISTRY , vol.17, no.13, pp.1469-1489, 2017 (SCI-Expanded)

2016

57. Micelle Mixtures for Coadministration of Gemcitabine and GDC-0449 To Treat Pancreatic Cancer

Karaca M., Dutta R., Ozsoy Y., Mahato R. I.

MOLECULAR PHARMACEUTICS , vol.13, no.6, pp.1822-1832, 2016 (SCI-Expanded)

2016

58. Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations

Erdal M. S., Ozhan G., Mat M. C., Ozsoy Y., Gungor S.

INTERNATIONAL JOURNAL OF NANOMEDICINE , vol.11, pp.1027-1037, 2016 (SCI-Expanded, Scopus)

2015

59. Ksantan Zamkının Uzatılmış Salımlı Tabletlerde Kullanımı

Özçelik E., MESUT B., ERGİNER Y.

Türkiye Klinikleri Eczacılık Bilimleri Dergisi , vol.4, no.2, pp.79-88, 2015 (Peer-Reviewed Journal)

2015

60. The Place of Drug Product Critical Quality Parameters in Quality by Design

Mesut B., Aksu B., Erginer Y.

TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.12, pp.75-92, 2015 (Scopus, TRDizin)

2012

61. Plasticizers in Transdermal Drug Delivery Systems

Gungor S., Erdal M. S., Ozsoy Y.

RECENT ADVANCES IN PLASTICIZERS , pp.91-112, 2012 (SCI-Expanded)

2011

62. Nasal route: an alternative approach for antiemetic drug delivery

Ozsoy Y., Gungor S.

EXPERT OPINION ON DRUG DELIVERY , vol.8, no.11, pp.1439-1453, 2011 (SCI-Expanded)

2011

63. Transdermal films of metoclopramide hydrochloride with terpenes as penetration enhancers: Design, characterization, in vitroevaluation and ATR-FTIR spectroscopic investigation on excised pig skin

ERDAL M. S., SAĞIRLI A. O., ERGİNER Y.

Asian Chemistry Letters , vol.16, no.1, pp.67-78, 2011 (Peer-Reviewed Journal)

2010

64. POLYMERIC MICELLES AND ITS NASAL APPLICATIONS

KAHRAMAN ŞİRİN E., ERGİNER Y.

ISTANBUL JOURNAL OF PHARMACY , vol.41, pp.121-139, 2010 (ESCI)

2009

65. Nasal Delivery of High Molecular Weight Drugs

Ozsoy Y., Gungor S., Cevher E.

MOLECULES , vol.14, no.9, pp.3754-3779, 2009 (SCI-Expanded)

2006

66. Preparation of ciprofloxacin hydrochloride loaded chitosan and pectin microspheres and their ın vivo evaluation in an animal experimental ımplant-related osteomyelitis model

Orhan Z., CEVHER E., Mülazımoğulu L., Gürcan D., Alper M., ARAMAN A. O., et al.

Journal of Bone and Joint Surgery , pp.270-275, 2006 (Scopus)

2005

67. Büyük Moleküllü İlaçlar İçin Yeni Salım Sistemleri

ERGİNER Y.

Güncel Eczacılık , no.136, pp.24-26, 2005 (Non Peer-Reviewed Journal)

2005

68. Transgenik hayvanlar ve üretilen ilaç etkin maddeleri

ERGİNER Y., YILDIZ PEKÖZ A.

Güncel Eczacılık , no.128, pp.28-30, 2005 (Non Peer-Reviewed Journal)

2004

69. Vehicle effects on in vitro release of tiaprofenic acid from different topical formulations.

ÖZSOY ERGİNER Y., GÜNGÖR S., CEVHER E., ARAMAN A. O.

IL Farmaco , no.59, pp.563-566, 2004 (Peer-Reviewed Journal)

2003

70. Nazal yol ile ilaç uygulamaları

ERGİNER Y., YILDIZ PEKÖZ A.

Güncel Eczacılık , no.115, pp.19-23, 2003 (Non Peer-Reviewed Journal)

2003

71. In vitro studies on sustained release suppository formulations of tiaprofenic acid with sucre fatty acid ester

GÜNGÖR S., Orlu M., ÖZSOY ERGİNER Y., ARAMAN A. O.

SCIENTIA PHARMACEUTICA , no.71, pp.357-364, 2003 (Scopus)

2002

72. Katı dozaj şekillerinin tatlarının maskelenmesi

ERGİNER Y.

Güncel Eczacılık , no.100, pp.39-41, 2002 (Non Peer-Reviewed Journal)

2002

73. Enhanced Dissolution Rate of Tiaprofenic Acid Using Gelucire 44/14

ERDAL M. S., ARAMAN A. O., Uzunkaya G., ÖZSOY ERGİNER Y.

SCIENTIA PHARMACEUTICA , pp.295-307, 2002 (Scopus)

2001

74. Preparation of sustained-release tiaprofenic acid beads

YILDIZ PEKÖZ A., Şensoy D., Baytokova A., ÖZSOY ERGİNER Y., ARAMAN A. O.

Journal of Faculty of Pharmacy of Istanbul Univesity , vol.34, pp.27-33, 2001 (Peer-Reviewed Journal)

1998

75. Akne tedavisinde kullanılan ilaçlar

ERGİNER Y., Bergişadi N.

Güncel Eczacılık , no.56, pp.24-26, 1998 (Non Peer-Reviewed Journal)

1997

76. Öksüz ilaçlar (Orphan Drugs)

ERGİNER Y., GÜNGÖR S.

Aktüel Eczacı , vol.37, pp.25-30, 1997 (Non Peer-Reviewed Journal)

1996

77. Sağlık ve Teknoloji

ERGİNER Y.

Sağlık , vol.2, pp.22-23, 1996 (Non Peer-Reviewed Journal)

1996

78. İnsan Nasıl Tembel Emek ile Rahatlıkla düNyayı Evine Taşır?

ERGİNER Y.

Aktüel Eczacı Sayı: 25. 34 (1996). , vol.25, pp.34-36, 1996 (Non Peer-Reviewed Journal)

1996

79. INTERNET

ERGİNER Y.

Aktüel Eczacı , vol.26, pp.14-16, 1996 (Non Peer-Reviewed Journal)

1995

80. Comparison of paracetamol suppositories commercially available in Turkey

ARAMAN A. O., ÖZSOY ERGİNER Y., GÜNGÖR S.

Acta Pharmaceutica Turcica , vol.37, no.4, pp.130-133, 1995 (Peer-Reviewed Journal)

1994

81. Investigation of the suppository base SF-9265 prepared in Turkey

ÖZSOY ERGİNER Y., ARAMAN A. O., GÜNGÖR S.

Acta Pharmaceutica Turcica , vol.36, no.4, pp.96-101, 1994 (Peer-Reviewed Journal)

1993

82. Identification and determination of colorants in chewing gums and jellies

ARAMAN A. O., ÖZSOY ERGİNER Y.

Acta Pharmaceutica Turcica , vol.35, pp.33-38, 1993 (Peer-Reviewed Journal)

1991

83. Determination of defibrotide based on bathochromasy

Erginer Y., Güven K.

Acta Pharmaceutica Sciencia , vol.33, no.1, pp.15-18, 1991 (Scopus)

1990

84. Adenozin Deaminaz Yetersizliği ve Adenozin Deaminaz Gen Değişim Terapisi

ERGİNER Y., ULUTİN A. N. T.

Dirim Sayı:3-4. 96-99 (1990). , pp.96-99, 1990 (Non Peer-Reviewed Journal)

1987

85. Turkey's Role in Science III. Study Using Corporate Index of SCI

Erginer Y., Güven K. C.

Acta Pharmaceutica Turcica , vol.29, pp.33-45, 1987 (Peer-Reviewed Journal)

Papers Presented at Peer-Reviewed Scientific Conferences

2023

1. SYSTEMATIC AND SEMIPREDICTIVE SCREENING STUDY OF STABILIZER AGENTS FOR FABRICATION OF PHYSICALLY STABLE DRUG NANOSUSPENSION

Pirincci Tok Y., Mesut B., Erginer Y.

4. INTERNATIONAL MARMARA SCIENTIFIC RESEARCH AND INNOVATION CONGRESS, İstanbul, Turkey, 11 - 12 March 2023, pp.37-38, (Summary Text)

2022

2. Development of Nasal Mucoadhesive In Situ Gel Spray Formulations for Antiviral Purpose

Özkan B., Altuntaş E., Çalık H., Erginer Y., Çakır Koç R.

IV. INTERNATIONAL AGRICULTURAL, BIOLOGICAL &LIFE SCIENCECONFERENCE, Edirne, Turkey, 22 - 31 August 2022, pp.197, (Summary Text)

2021

3. In vitro characterization of micelles based drug delivery systems for ocular fungal infections

Durgun M. E., Mesut B., Güngör S., Erginer Y.

CRS Virtual Annual Meeting 2021, 25 - 29 July 2021, (Unpublished)

2021

4. Development of the Micellar Based Ocular In Situ Gelling Systems of Posaconazole with Quality by Design (QbD) Approach

Durgun M. E., Mesut B., Güngör S., Erginer Y.

13th International Symposium on Pharmaceutical Sciences (ISOPS), 22 - 25 June 2021, pp.41-42, (Full Text)

2021

5. Optimization Studies of Alfuzosin Tablet Formulation Using Machine Learning Models

Başkor A., Mesut B., Aksu N. B., Erginer Y.

4th International Conference on Data Science and Applications (ICONDATA'21), Muğla, Turkey, 4 - 05 June 2021, pp.32, (Summary Text)

2021

6. Machine Learning Models and Statistical Dexketoprofen Pharmaceutical Dosage of Approaches Application In The Form

Başkor A., Pirinçci Tok Y., Mesut B., Erginer Y., Uçar T.

4th International Conference on Data Science and Applications (ICONDATA’21), Muğla, Turkey, 4 - 06 June 2021, pp.14, (Summary Text)

2021

7. Effect of Ingredients and Physicochemical Characteristics of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers on Drug Release Profiles

Üner B., Özdemir S., Taş Ç., Üner M., Erginer Y.

9. International Drug Chemistry Conference, Antalya, Turkey, 8 - 11 April 2021, pp.125, (Summary Text)

2021

8. Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Application in Treatment of Allergic Reactions of the Skin: Optimization of Formulation Parameters

Üner B., Özdemir S., Taş Ç., Üner M., Erginer Y.

Euro Asia 8th International Congress on Applied Sciences, Toskent, Uzbekistan, 15 - 16 March 2021, pp.248-255, (Full Text)

2020

9. Design, Preparation and Evaluation of Taste-Masked Dexketoprofen of Orally Disintegrating Tablet By Using QbD Approach

Pirinçci Tok Y., Mesut B., Erginer Y.

The 1st International Electronic Conference on Pharmaceutics, Basel, Switzerland, 1 - 03 December 2020, pp.1, (Summary Text)

2020

10. D-α-tocopheryl Polyethylene Glycol 1000 Succinate (TPGS) Micelles Based In Situ Gelling Systems For Ocular Anti-fungal Therapy

Durgun M. E., Güngör S., Erginer Y.

Controlled Release Society (CRS) Annual Virtual Meeting 2020, 29 June - 02 July 2020, pp.1, (Summary Text)

2020

11. Optimization and Characterization of Posaconazole Loaded Nanomicelles for Ocular Delivery

Güngör S., Durgun Kılıç M. E., Kahraman E., Erginer Y.

XIII Spanish-Portuguese Conference on Controlled Drug Delivery, A-Coruna, Spain, 22 - 24 January 2020, pp.1-2, (Full Text)

2019

12. Risk Assesment of Taste Masked Orally Disintegrating Tablets of Dexketoprofen

Pirinçci Tok Y., Mesut B., Erginer Y., Yetilmezsoy K.

7th International BAU Drug Design Congress, İstanbul, Turkey, 19 - 21 December 2019, pp.164, (Full Text)

2019

13. Nanomicellar carriers of posaconazole: A novel approach to improve its ocular bioavailability

Durgun Kılıç M. E., Kahraman E., Güngör S., Özsoy Y.

8th BBBB International Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019, pp.1-2, (Full Text)

2019

14. Bioequivalence assessment of generic topical gels using in vitro methods

Kalami E., Kahraman E., Dedeoğlu E., Gürbüz K., Güngör S., Özsoy Y.

8th BBBB International Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019, pp.1-2, (Summary Text)

2019

15. Self Nanoemulsifying Drug Delivery System Formulation Design of Aprepitant

Nazlı H., Mesut B., Erginer Y.

8th BBBB International Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019, pp.138-139, (Full Text)

2019

16. Development of Melatonin-Containing Orally Disintegrated Tablets Using Artificial Intelligensys Methodology

Mesut B., Alkan B., Pirinçci Tok Y., Erginer Y., Yetilmezsoy K.

8th BBBB International Conference on Pharmaceutical Science, İzmir, Turkey, 14 - 16 October 2019, pp.72-73, (Full Text)

2019

17. Preformulation Studies of Self Nanoemulsifying Drug Delivery System (SNEDDS) Formulation of Deferasirox

Alghananim A., Özalp Y., Mesut B., Güngör S., Erginer Y.

8th BBBB International Conference on Pharmaceutical Sciences , İzmir, Turkey, 14 - 16 October 2019, pp.285-286, (Full Text)

2019

18. Development of Aripiprazole Orally Disintegrating Film Formulation By Using Quality by Design Approach

Mesut B., Kalayı M., Aksu B., Erginer Y.

8th BBBB International Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019, pp.312-313, (Full Text)

2019

19. Development and Mechanical Modeling of Si1-xGex/Si MQW Based Uncooled Microbolometers in a 130 nm BiCMOS

Baristiran-Kaynak C., Goeritz A., Yamamoto Y., Wictstruck M., Stocchi M., Unal K. E., et al.

19th IEEE Topical Meeting on Silicon Monolithic Integrated Circuits in RF Systems (SiRF), Florida, United States Of America, 20 - 23 January 2019, pp.122-124, (Full Text)

2018

20. The Application of Artificial Neural Networks for the Development of Topical Flurbiprofen Microemulsion

Mesut B., Gürbüz A., Erdal M. S., Aksu B., Erginer Y., Güngör S.

12th Central European Symposium on Pharmaceutical Technology and Regulatory Affairs, Szeged, Hungary, 20 - 22 September 2018, pp.107-108, (Full Text)

2018

21. The Application Of Artificial Neural Networks For The Development Of Topical Flurbiprofen Microemulsions

MESUT B., ERDAL M. S., AKSU N. B., ERGİNER Y., GÜNGÖR S.

12th CESPT, 20 - 22 September 2018, (Summary Text)

2018

22. Development and Optimization of Orodispesible Films Containing Quetiapine Fumarate

Özcan E., MESUT B., ERGİNER Y.

International Pharmaceutical Technology Symposium, Antalya, Turkey, 17 - 19 September 2018, pp.13, (Full Text)

2018

23. Self Nanoemulsifying Drug Delivery System (SNEDDS) Formulation Design of Aprepitant

Nazlı H., MESUT B., tekarslan h., ERGİNER Y.

International Pharmaceutical Technology Symposium, Antalya, Turkey, 17 - 19 September 2018, pp.12, (Full Text)

2017

24. QBD-Based Development and Characterisation of Microemulsion Formulations for Improved Skin Delivery of Flurbiprofen

GÜRBÜZ A., MESUT B., ERDAL M. S., Aksu B., ERGİNER Y., GÜNGÖR S.

2nd International Gazi Pharma Symposium Series, Ankara, Turkey, 11 - 13 October 2017, pp.36, (Full Text)

2017

25. QbD based development and characterization of microemulsion formulations for improved skin delivery of flurbiprofen

GÜRBÜZ A., MESUT B., ERDAL M. S., Aksu B., ERGİNER Y., GÜNGÖR S.

2nd International Gazi Pharma Symposium Series, Ankara, Turkey, 11 - 13 October 2017, pp.1, (Full Text)

2017

26. Evaluation of cytotoxicity of of budesonide-loaded Snedds on human colon cancer cell lines

MESUT B., TEKARSLAN ŞAHİN Ş. H., ERGİNER Y.

2nd International Gazi Pharma Symposium Series, İstanbul, Turkey, 11 - 13 October 2017, pp.96, (Full Text)

2017

27. Novel topical nano-carriers to improve penetration of tacrolimus into the skin

KAHRAMAN E., NEŞETOĞLU N., GÜNGÖR S., ÜNAL D. Ş., ERGİNER Y.

FIP World Congress of Pharmacy and Pharmaceutical Sciences 2017, Seoul, South Korea, 10 - 14 September 2017, (Full Text)

2017

28. Design of extended release tablet formulation using artificial neutral network programs

ÖZÇELİK E., MESUT B., AKSU N. B., ERGİNER Y.

CRS Annual Meeting 2017, 16 - 19 July 2017, (Summary Text)

2017

29. Design of Extended Release Tablet Formulation Using Artificial Neural Network

Özçelik E., Mesut B., Aksu B., Erginer Y.

CRS Annual Meeting & Exposition, Massachusetts, United States Of America, 16 - 19 July 2017, pp.1, (Summary Text)

2017

30. Penetration Enhancer-Containing Nanomicelles for Topical Delivery: Impact on Skin Barrier

ERGİNER Y., KAHRAMAN E., GÜNGÖR S.

Controlled Release Society Annual Meeting & Exposition), Boston, United States Of America, 16 - 19 July 2017, pp.3487, (Full Text)

2017

31. Tacrolimus Loaded Pluronic®F127 Micelles: Cellular Viability and Cell Growth for Ocular Administration

KAHRAMAN E., KARACA M., TEKARSLAN ŞAHİN Ş. H., YILDIZ PEKÖZ A., ERGİNER Y., GÜNGÖR S.

The 6th Pharmaceutical Sciences World Congress, Stockholm, Sweden, 21 - 24 May 2017, (Full Text)

2017

32. Budesonide Self-microemulsion Formulation as a oral Drug Delivery System

Mesut B., Erginer Y.

6th Pharmaceutical Sciences World Congress 2017, Stockholm, Sweden, 21 - 24 May 2017, pp.1, (Summary Text)

2017

33. Tacrolimus loaded Pluronic F127 micelles: Cellular viability and cell growth for ocular administration

KAHRAMAN E., KARACA M., TEKARSLAN ŞAHİN Ş. H., YILDIZ PEKÖZ A., GÜNGÖR S., ERGİNER Y.

6th Pharmaceutical Sciences World Congress, Stockholm, Sweden, 21 - 24 May 2017, (Full Text)

2017

34. Budesonide self-nanoemulsion formulation as an oral drug delivery system: Preparation,characterization and cytotoxicity studies

Mesut B., Tekarslan Şahin Ş. H., Erginer Y.

2nd World Conference on Technology, Innovation and Entrepreneurship, İstanbul, Turkey, 12 - 14 May 2017, pp.54, (Summary Text)

2017

35. Improved drug localization in the skin via topical nano-micellar carriers

KAHRAMAN E., NEŞETOĞLU N., ÖZTAŞ E., ÖZHAN G., ÜNAL D. Ş., GÜNGÖR S., et al.

22ND INTERNATIONAL BIOMEDICAL SCIENCE & TECHNOLOGY SYMPOSIUM, Ankara, Turkey, 12 - 14 May 2017, (Full Text)

2017

36. Artificial Neural Networks in Pharmaceutical Technology

MESUT B., TEKARSLAN ŞAHİN Ş. H., ERGİNER Y.

2nd World Conference on Technology, Innovation and Entrepreneurship, İstanbul, Turkey, 12 - 14 May 2017, (Full Text)

2017

37. Implementing of Quality By Design Approach Using Different Computerized Systems

Mesut B., Aksu B., Erginer Y.

2nd European Conference on Pharmaceutics, Krakow, Poland, 3 - 04 April 2017, pp.1, (Full Text)

2016

38. NİŞASTA ESASLI BİYOYAPIŞABİLEN POLİMERLERİN SENTEZİ VE İLAÇ TAŞIYIVI SİSTEMLERDE UYGULAMALARI

PABUCCUOĞLU S., PABUCCUOĞLU S. K., DEMİR K., GÖK M. K., CEVHER E., ERGİNER Y., et al.

ÜSİMP PATENT FUARI 16 ÜNİVERSİTE PATENTLERİ SANAYİ İLE BULUŞUYOR, 8-9 KASIM 2016, İstanbul, Turkey, 8 - 09 November 2016, pp.1, (Full Text)

2016

39. The Importance of the Self Nano/Microemulsifying Drug Delivery Systems (SN/MEDDs) for Oral Drug Delivery

MESUT B., TEKARSLAN ŞAHİN Ş. H., ERGİNER Y.

4th BAU DRUG DESIGN Congress, İstanbul, Turkey, 13 - 15 October 2016, (Full Text)

2016

40. Development of topical microemulsions of naftifine and evaluation of their antifungal activity

ERDAL M. S., GÜNGÖR S., BİRTEKSÖZ TAN A. S., DÖŞLER S., ERGİNER Y.

4th Conference of Innovation in Drug Delivery, Antibes, France, 25 - 28 September 2016, pp.1, (Full Text)

2016

41. Design and Optimization of Self-Nanoemulsifying Drug Delivery systems (SNEDDs) Containing Budesonide

MESUT B., ERGİNER Y.

International Pharmaceutical Technology Symposium, Antalya, Turkey, 18 - 21 September 2016, pp.172-174, (Full Text)

2016

42. SNEEDs formulation of Budesonide to improve its solubility Optimization and in vitro release studies

ERGİNER Y., MESUT B.

Drug Formulation &Bioavailability Congress, 5 - 07 September 2016, (Summary Text)

2017

43. SNEDDs Formulation of Budesonide to İmprove its Solubility: Optimization and in vitro release studies

Erginer Y., Mesut B.

Drug Formulation & Bioavailability Congress, Beijing, China, 5 - 07 September 2017, pp.51, (Summary Text)

2016

44. Preliminary Studies on Topical Polymeric Micellar Formulations of Immunomodulatory Drugs

KAHRAMAN E., GÜNGÖR S., ÖZSOY Y.

Skin Forum 15th Annual Meeting, Londra, United Kingdom, 21 - 22 June 2016, pp.1-2, (Summary Text)

2015

45. Importance Of Artificial Intelligence Applicatıons For Drug Development With Quality By Design (Qbd) Approach

ERGİNER Y., Yrğrn G., Aksu B., CEVHER E.

INTERNATIONAL MULTIDISCIPLINARY SYMPOSIUM ON Drug Research & Development (ILARUD), Eskişehir, Turkey, 25 - 29 October 2015, pp.1, (Full Text)

2015

46. Optimization of an orodispersible tablet formulation containing Metoprolol tartrate

ERGİNER Y., Yeğen G., Aksu B., CEVHER E.

2015 AAPS Annual Meeting and Exposition, Orlando, United States Of America, 25 - 29 October 2015, pp.1, (Full Text)

2015

47. Formulation design and optimisation of oral disintegrating tablet containing Alfuzosin hydrochloride with Quality by Design Approach

ERGİNER Y., Güncan G., Yeğen G., Aksu B.

2015 AAPS Annual Meeting and Exposition, Orlando, United States Of America, 25 - 29 September 2015, pp.1, (Full Text)

2015

48. Formulation design of the oral disintegrating tablets ıncluding alfuzosin hydrochloride with risk evaluation and artificial neural networks

ÖZSOY Y., AKSU B., GÜNCAN G., YEĞEN G.

BBBB 2015. 6th Baltic Bled Balatan Bosphorus Conference on Pharmaceutical Sciences, Helsinki, Finland, 10 - 12 September 2015, pp.10, (Full Text)

2015

49. Risk Assessment Trials in The Aspect of Quality by Design

ERGİNER Y., Yeğen G., Aksu B., CEVHER E.

, International Eurasia Pharmacy Congress, Erzincan, Turkey, 3 - 07 September 2015, pp.1, (Full Text)

2015

50. Optimization of Electrospun Nanofiber Mats for Transdermal Delivery

Gençtürk A., KAHRAMAN E., ÖZHAN G., GÜNGÖR S., ERGİNER Y., Saraç A. S.

Controoled Release Society Annual Meeting 2015, Edinburgh, United Kingdom, 26 - 29 July 2015, pp.1-2, (Full Text)

2015

51. Quetiapine Fumarate Sustained Release Tablet Formulation Design By Using Inform V.4 ANN Program

Özçelik E., Mesut B., Aksu B., Erginer Y.

11th International Symposium on Pharmaceutical Sciences, Ankara, Turkey, 9 - 12 June 2015, pp.129, (Full Text)

2015

52. Design of an orally disintegrating tablet formulation containing Metoprolol tartrate with the help of artificial intelligence programs,

ERGİNER Y., Yeğen G., Aksu B., CEVHER E.

Istanbul University World Conference On Technology, Innovation And Entrepreneurship, İstanbul, Turkey, 28 - 30 May 2015, pp.1, (Full Text)

2015

53. A Novel Vaginal Tablet For The Estrous Synchronization In Sheeps

GÖK M. K., PABUCCUOĞLU S. K., DEMİR K., CİRİT Ü., CEVHER E., ERGİNER Y., et al.

II. International VETistanbul Group Congress, St.Petersburg, Russia, 7 - 09 April 2015, pp.666-667, (Full Text)

2014

54. Optimisation of ondansetron orally disintegrating tablets using artificial neural networks

ERGİNER Y., Aksu B., Yeğen G., PURİSA S., CEVHER E.

17th International Pharmaceutical Technology Symposium - IPTS, Antalya, Turkey, 8 - 10 September 2014, pp.1, (Full Text)

2014

55. VEHICLE COMPOSITION EFFECTS ON IN VITRO TRANSSCLERAL IONTOPHORETIC TRANSPORT OF MOXIFLOXACIN

MESUT B., ERGİNER Y., GÜNGÖR S.

17th International Pharmaceutical Technology Symposium, Antalya, Turkey, 8 - 10 September 2014, pp.294-296, (Full Text)

2014

56. The design of an orodispersible tablet formulation containing metoprolol tartrate with the quality by design (QbD) approach

ERGİNER Y., Yeğen G., Aksu B., CEVHER E.

17th International Pharmaceutical Technology Symposium - IPTS, Antalya, Turkey, 8 - 10 September 2014, pp.1, (Full Text)

2014

57. IN VITRO TRANSSCLERAL IONTOPHORESIS OF MOXIFLOXACIN HYDROCHLORIDE

MESUT B., ERGİNER Y., GÜNGÖR S.

41st Annual Meeting & Exposition of the Controlled Release Society, Chicago, United States Of America, 13 - 16 July 2014, pp.125, (Full Text)

2014

58. Optimisation of ondansetron orally disintegrating tablets using artificial neural networks.

ERGİNER Y., Aksu B., Yeğen G., PURİSA S., CEVHER E.

2014 AAPS Annual Meeting and Exposition, San Diego, United States Of America, 19 - 21 May 2014, pp.1, (Full Text)

2014

59. Optimization Studies of Quetiapine Fumarate Modified Release Tablets By Using Artificial Neural Network Programs

Özçelik E., Mesut B., Aksu B., Erginer Y.

9th World Meeting on Pharmaceutics, Biopharmaceutics, and Pharmaceutical Technology, Lisbon, Portugal, 31 March - 03 April 2014, pp.1-2, (Full Text)

2013

60. Quetiapine Fumarate Modified Release Tablet Formulations Optimization Based on Genetic Algorithm Program

Özçelik E., Mesut B., Aksu B., Erginer Y.

International Multidisciplinary Symposium on Drug Research & Development, Antalya, Turkey, 28 - 30 November 2013, pp.1, (Summary Text)

2013

61. Quetiapine fumarate sustained release tablet formulations design by using artificial neural network

Özçelik E., Mesut B., Aksu B., Erginer Y.

EuPat 6 European QbD&PAT Conference , Porto, Portugal, 23 - 24 September 2013, pp.40-41, (Summary Text)

2013

62. Koyunlarda Östrus Senkronizasyonu Amaçli CIDR ve Süngere Alternatif Olarak Kullanilabilecek Yeni Vajinal Tablet Üretimi Ve Uygulamaları

PABUCCUOĞLU S. K., GÖK M. K., DEMİR K., CİRİT Ü., CEVHER E., ÖZSOY ERGİNER Y., et al.

VII.Ulusal Reprodüksiyon ve Suni Tohumlama Bilim Kongresi (Uluslararası Katılımlı), Kars, Turkey, 1 - 04 July 2013, vol.1, no.1, pp.65-66, (Summary Text)

63. Nişasta Esaslı Biyoyapışabilen Polimerlerin Sentezi Ve İlaç Taşıyıcı Sistemlerde Uygulamaları

BAP Koordinasyon Birimi İ. Ü., PABUCCUOĞLU S. K., GÖK M. K., DEMİR K., Cirit Ü., CEVHER E., et al.

2. Ege Ar-Ge ve Teknoloji Günleri, AreGE2 Patent, İzmir, Turkey, (Full Text)

2012

64. Nişasta Esaslı Biyoyapışabilen Polimerlerin Sentezi ve İlaç Taşıyıcı Sistemlerde Uygulamaları

BAP Koordinasyon Birimi İ., PABUCCUOĞLU S. K., GÖK M. K., DEMİR K., CİRİT Ü., CEVHER E., et al.

2. Ege Ar-Ge ve Teknoloji Günleri, AreGE2 Patent, İzmir, Turkey, 1 - 04 November 2012, (Full Text)

2012

65. In vitro and ex vivo evaluation of verapamil loaded nasal inserts.

Yenil Ö., Kahraman E., ERGİNER Y.

16th International Pharmaceutical Technology Symposium, Antalya, Turkey, 10 - 12 September 2012, pp.261-262, (Full Text)

66. In Situ Gelling Nasal Inserts of Verapamil Hcl: In Vitro And Ex Vivo Evaluation

Yenil Ö., Kahraman E., ERGİNER Y.

16th International Pharmaceutical Technology Symposium, Turkey, (Full Text)

2012

67. Optimization of Alfuzosin Tablet Formulations By Using Genetic Algorithm Program

Mesut B., Aksu B., Erginer Y.

EuPat 5 European QbD&PAT Conference, Ghent, Belgium, 9 - 10 May 2012, pp.33, (Summary Text)

2011

68. Optimization of Alfuzosin HCl Tablet Formulations Using Artificial Neural Network

Mesut B., Aksu B., Erginer Y.

4th BBBB Bled- International Conference on Pharmaceutical Sciences, Ljubljana, Slovenia, 29 September - 01 November 2011, pp.94-95, (Full Text)

2011

69. Optimization of Alfuzosin HCl Modified Release Tablet Formulations Using Artificial Neural Network

Aksu B., Mesut B., Erginer Y.

5th International Congress on Pharmaceutical Engineering, Graz, Austria, 29 - 30 September 2011, pp.81, (Summary Text)

2011

70. Optimization of Alfuzosin Sustained Release Tablet Formulations Using Artificial Neural Network

Mesut B., Aksu B., Erginer Y.

18 th International Syposium on Microencapsulation, Antalya, Turkey, 12 - 14 September 2011, pp.216-219, (Full Text)

2009

71. In vitro evaluation of indomethacin loaded solid lipid microparticles

ERDAL M. S., GÜNGÖR S., ERGİNER Y., ARAMAN A. O.

17th International Symposium on Microencapsulation, Nagoya, Japan, 29 September - 01 October 2009, pp.1, (Full Text)

2009

72. Evaluation of penetration enhancement effect of terpenes on a highly lipophilic compound with ATR-FTIR spectroscopy

ERDAL M. S., ERGİNER Y., GÜNGÖR S.

69th FIP World Congree of Pharmacy and Pharmaceutical Sciences, İstanbul, Turkey, 3 - 08 September 2009, pp.1, (Full Text)

2009

73. In vitro Evaluation of Nasal Inserts of Verapamil HCl

ERGİNER Y., YENİL Ö., ÖZKIRIMLI S.

35th Annual Meeting & Exposition of the Controlled Release Society, New York, United States Of America, 12 - 16 July 2009, pp.1, (Full Text)

2009

74. Preliminary In vitro Studies on Transdermal Patches of Metoclopramide Hydrochloride

ERGİNER Y., AKTAR B., GÜNGÖR S.

2nd PharmSciFair. Premier European Platform for Advancing Pharmaceutical Sciences, Nice, France, 8 - 12 June 2009, pp.1, (Full Text)

2007

75. Östrusun Kontrolü Amaçlı Hormon Salımında Kullanılabilen Mukozaya Yapışabilen Polimerlerin Üretimi

GÖK M. K., PABUCCUOĞLU S. K., CEVHER E., ERGİNER Y., Bacınoğlu S., Cirit Ü., et al.

IV. Ulusal Reprodüksiyon ve Suni Tohumlama Bilim Kongresi, Antalya, Turkey, 25 - 28 October 2007, pp.60-61, (Summary Text)

76. Östrusun Kontrolu Amaçlı Hormon Salımında Kullanılabilen Mukozaya Yapışan Polimerlerin Üretimi

GÖK M. K., ÖZGÜMÜŞ S., CEVHER E., BACINOĞLU S., ERGİNER Y., CİRİT Ü., et al.

4. Ulusal Reprodüksiyon Ve Suni Tohumlama Kongresi, Antalya, Turkey, pp.60-61, (Summary Text)

2007

77. Heparin’in uygulanmasında yeni Farmasötik yaklaşımlar

ERGİNER Y.

VII.Ulusal Tromboz, Hemostaz ve Anjioloji Kongresi, Adana, Turkey, 4 - 06 May 2007, pp.1, (Full Text)

2007

78. Düşük Molekül Ağırlıklı Heparinin Jel Formülasyonları Üzerine In-Vitro Çalışmalar

ERGİNER Y., YILDIZ PEKÖZ A., GÜNGÖR S., ARAMAN A. O.

VII. Ulusal Tromboz, Hemostaz ve Anjioloji Kongresi, Adana, Turkey, 4 - 06 May 2007, pp.1, (Full Text)

2007

79. in vitro and in vivo studies on ondansetron HCl loaded biodegradable mıcrospheres

ERGİNER Y., GÜNGÖR S., OKYAR A., TOKER S., Baktır G.

Pharmaceutical Sciences World Congress, Amsderdam, Netherlands, 22 - 25 April 2007, pp.1, (Full Text)

2007

80. Primary Packaging for Pharmaceuticals and its Importance for the Future

ERGİNER Y., ARAMAN A. O.

SHOTT Pharma Symposium, İstanbul, Turkey, 14 March 2007, pp.1, (Full Text)

2006

81. Nazal yolla uygulanan modern terapötik sistemler

ERGİNER Y.

50. Yıl İstanbul Eczacı Odası İstanbul Eczacılık Kongresi, İstanbul, Turkey, 8 - 10 December 2006, pp.1, (Full Text)

2006

82. İlaçların nazal yoldan uygulanması

ERGİNER Y.

Mediterranean Pharmacy Congress, Antalya, Turkey, 13 - 16 October 2006, pp.1, (Full Text)

2006

83. Heparin Microparticles for Pulmonary Administration

ERGİNER Y., YILDIZ PEKÖZ A., ARAMAN A. O.

33rd Annual Meeting & Exposition of the Controlled Release Society, Vienna, Austria, 22 - 26 July 2006, pp.1, (Full Text)

2006

84. Vücutta Parçalanabilen Heparin Mikrokürelerinin Nazal Yol ile Uygulanması

ERGİNER Y., YILDIZ PEKÖZ A., OKYAR A., Baktır G., ARAMAN A. O.

VI. Ulusal Tromboz, Hemostaz ve Anjiolojik Kongresi, İzmir, Turkey, 5 - 07 May 2006, pp.1, (Full Text)

2006

85. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylocuccus aureus (MRSA) with prepared microspheres

ERGİNER Y., CEVHER E., Orhan Z., Müzazımoğlu L., Şensoy D., Alper M., et al.

5th World Meeting on Pharmaceutics and Pharmaceutical Technology, Cenevre, Switzerland, 27 - 30 March 2006, pp.1, (Full Text)

2005

86. Effects of terpenes on Verapamil HCl permeation through excised rat skin from matrix-type transdermal systems and pharmacodynamic activity

GÜNGÖR S., Bektaş A., ALP F. İ., ÖZSOY ERGİNER Y., UYDEŞ DOĞAN B. S., ARAMAN A. O., et al.

Pharmaceutical Sciences Fair& Exhibition, EUFEPS, Nice, France, 12 - 17 June 2005, pp.1, (Full Text)

2005

87. Effect of terpenes on verapamil hydrochloride permeation through excised rat skin from matrix-type transdermal systems and pharmacodynamic activity in rats

ERGİNER Y., GÜNGÖR S., BEKTAŞ A., ALP YILDIRIM F. İ., UYDEŞ DOĞAN B. S., ÖZDEMİR O., et al.

PharmSciFair, Pharmaceutical Sciences Fair & Exhibition, Nice, France, 12 - 17 June 2005, pp.1, (Full Text)

2004

88. Preparation of Ciprofloxacin HCl Loaded Microspheres and In vivo Evaluation with Orthopaedics Studies

ERGİNER Y., ORHAN Z., CEVHER E., Mülazımoğlu L., GÜRCAN D., ARAMAN A. O.

Pharmaceutical Sciences World Congress (PSWC 2004), Kyoto, Japan, 30 May - 03 June 2004, pp.1, (Full Text)

2004

89. In vitro and In vivo Evaluation of Ciprofloxacin HCl Loaded Chitosan Microspheres by Spray-Drying Method and In Vivo Evaluation for Nasal Administration

ERGİNER Y., GÜRCAN D., OKYAR A., KARAKOÇ B., BAKTIR G., GERÇEKER A.

European Conference on Drug Delivery and Pharmaceutical Technology, Sevilla, Spain, 10 - 12 May 2004, pp.1, (Full Text)

2004

90. Biodegredable heparin microspheres: II. Nasal administration of heparin microspheres

ERGİNER Y., YILDIZ PEKÖZ A., OKYAR A., ARAMAN A. O., BAKTIR G.

5th International Conference and Workshop on Cell Culture and In-vitro models for Drug Absorption and Delivery, Saarbrücken, Germany, 25 February - 05 March 2004, pp.1, (Full Text)

2003

91. Preliminary in vitro studies on transdermal matrix formulations of verapamil hydrochloride using pectin

ERGİNER Y., GÜNGÖR S., BEKTAŞ A., ARAMAN A. O.

Symposium Skin and Formulation, Paris, France, 23 - 24 October 2003, pp.1, (Full Text)

2003

92. In vitro studies on topical gel formulations of low molecular weight heparin

ERGİNER Y., YILDIZ PEKÖZ A., GÜNGÖR S., ARAMAN A. O.

Symposium Skin and Formulation, Paris, France, 23 - 24 October 2003, pp.1, (Full Text)

2002

93. Studies on indomethacin loaded microparticles with glyceryl behenate

ERGİNER Y., ERDAL M. S., GÜNGÖR S., ARAMAN A. O.

3rd International Postgraduate Research Symposium on Pharmaceutics, İstanbul, Turkey, 16 - 18 September 2002, pp.1, (Full Text)

2002

94. Studies on topical formulations of tiaprofenic acid

ERGİNER Y., GÜNGÖR S., CEVHER E.

3rd International Postgraduate Research Symposium on Pharmaceutics, İstanbul, Turkey, 16 - 18 September 2002, pp.1, (Full Text)

2002

95. Preliminary Studies on Sustained Release Suppository Formulations of Tiaprofenic Acid with Sucrose Ester

ERGİNER Y., GÜNGÖR S., ORLU M., ARAMAN A. O.

11th International Pharmaceutical Technology Symposium, İstanbul, Turkey, 9 - 11 September 2002, pp.1, (Full Text)

2000

96. Effects of Gelucire?44/14 on the Dissolution of Tiaprofenic Acid from Hard Gelatin Capsules

ERGİNER Y., ERDAL M. S., UZUNKAYA G., ŞENSOY D., ARAMAN A. O.

The Second International Postgraduate Research Symposium on Pharmaceutics, İstanbul, Turkey, 6 - 08 September 2000, pp.1, (Full Text)

2000

97. Investigations on Mefenamic Acid Sustained-Release Tablets with Water-Insoluble Gel

ERGİNER Y., YILDIZ PEKÖZ A., GÜNGÖR S., CEVHER E., ARAMAN A. O.

The Second International Postgraduate Research Symposium on Pharmaceutics, İstanbul, Turkey, 6 - 08 September 2000, pp.1, (Full Text)

2000

98. Preparation of Sustained-release Tiaprofenic Acid Beads

ERGİNER Y., YILDIZ PEKÖZ A., ŞENSOY D., Baytokova A.

The Second International Postgraduate Research Symposium on Pharmaceutics, İstanbul, Turkey, 6 - 08 September 2000, pp.1, (Full Text)

1998

99. In vivo studies on the nasal preparations of ciprofloxacin hydrochloride

ERGİNER Y., Tunçel T., CAN A., AKEV N., BİRTEKSÖZ TAN A. S., GERÇEKER A.

Hacettepe University, 9 th International Pharmaceutical Technology Symposium, Turkey, 1 - 04 December 1998, pp.91, (Full Text)

1996

100. Genetic immunisation via mucosal and parenteral routes using microsphere carriers

Alpar H., ERGİNER Y., Bowen J., Eyles J., Conway B., Williamson E.

23rd International Symposium on Controlled Release of Bioactive Materials, Kyoto, Japan, 7 - 10 July 1996, pp.861-862, (Full Text)

1989

101. THE PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF DEFIBROTIDE - A NEW PROFIBRINOLYTIC, ANTITHROMBOTIC AND ANTIPLATETLET SUBSTANCE

ULUTIN O., BALKUVULUTIN S., UGUR M., ULUTIN T., ERGİNER Y., CIZMECI G.

INTERNATIONAL SCIENTIFIC SYMP ON FIBRINOGEN, THROMBOSIS, COAGULATION, AND FIBRINOLYSIS, Taipei, Taiwan, 30 August - 01 September 1989, vol.281, pp.429-438, (Full Text)

Books

2025

1. Nano-based nasal delivery of biomacromolecules: a myriad of opportunities

Sinani G., Güngör S., Erginer Y., Cevher E.

in: Bioactive‐Based Nanotherapeutics, Rakesh K. Sindhu (Editor),Sumitra Singh (Editor),Evren Algin Yapar (Editor), Editor, John Wiley & Sons Inc, New Jersey, pp.151-198, 2025

2025

2. Nanocrystals Based Approach in Colon Targeting

Pirinçci Tok Y., Güngör S., Erginer Y.

in: Nanocarriers Based Colon Targeting Design, Development, Mechanism and Case Studies, Lalit Kumar,Yashwant Pathak, Editor, Academic Press , London, pp.569-600, 2025

2025

3. Self nanoemulsifying drug delivery systems in colon targeting

Demiralp B., Al-Mohaya M., Çelik Y. S., Güngör S., Erginer Y.

in: Nanocarriers Based Colon Targeting, Lalit Kumar,Yashwant V. Pathak, Editor, Elsevier Science, Oxford/Amsterdam , Massachusetts, pp.689-716, 2025

2024

4. TARGETING STRATEGIES WITH NEW DRUG DELIVERY SYSTEMS IN CANCER THERAPY

ÇELİK Y. S., DEMİRALP B., ERGİNER Y.

in: CANCER: FROM GENOMICS TO PHARMACEUTICS, KARAKAŞ ZEYNEP, ERDAL MERYEM SEDEF, SAYİTOĞLU MÜGE, SOLUK TEKKEŞİN MERVA, Editor, Istanbul University, pp.240-262, 2024

2023

5. Nasal Delivery of High Molecular Weight Drugs: Recent Trends and Clinical Evidence

Kahraman Şirin E., Güngör S., Erginer Y.

in: Nasal Drug Delivery, Yashwant V. Pathak,Hemant K. S. Yadav, Editor, Springer Nature, Basel, pp.253-277, 2023

2023

6. Nose-to-Brain Delivery of Peptides and Proteins

Durgun M. E., Çamlık G., Değim İ. T., Erginer Y.

in: Nasal Drug Delivery, Y.V. Pathak,H.K.S. Yadav, Editor, Springer, London/Berlin , Basel, pp.169-187, 2023

2022

7. Polymeric micellar nanocarriers: topical treatment of inflammatory diseases

Kahraman Şirin E., Durgun M. E., Güngör S., Erginer Y.

in: Polymeric Micelles for Drug Delivery, Prashant Kesharwani,Khaled Greish, Editor, Elsevier Science, Oxford/Amsterdam , Amsterdam, pp.115-143, 2022

2022

8. Drug Release, Susceptibility and Time-Kill Assays to Develop Novel Anti-Infective Drugs

Esentürk Güzel İ., Durgun M. E., Güngör S., Erginer Y.

in: Encyclopedia of Infection and Immunity, Nima Rezaei,Rowena Jenkins,Fanny Lanternier,Fernando Cobo,Fabrizio Bruschi,Giovanni Benelli,Federico Iovino,Hans D. Ochs, Editor, Elsevier Science, Oxford/Amsterdam , Oxford, pp.640-651, 2022

2022

9. Herbal bioactives for ocular drug delivery systems

Alğın Yapar E., Durgun M. E., Esentürk İ., Güngör S., Erginer Y.

in: Herbal Bioactive-Based Drug Delivery Systems Challenges and Opportunities, Inderbir Bakshi,Rajni Bala,Reecha Madaan,Rakesh Sindhu, Editor, Elsevier Science, Oxford/Amsterdam , Oxford, pp.25-61, 2022

2021

10. Frontiers in Anti-infective Agents

Durgun Kılıç M. E., Güngör S., Erginer Y.

Bentham Science Publishing, Singapore, 2021

2021

11. Anti-Infective Agents in Ocular Treatment and New Approaches

Durgun M. E., Güngör S., Erginer Y.

in: Frontiers in Anti-infective Agents, Singh P.,Kumar V.,Karpoormath R., Editor, Bentham Science Publishers, Singapore, pp.1-41, 2021

2020

12. Recent advances in biopolymer-based transdermal patches

Güngör S., Kahraman E., Erdal M. S., Özsoy Y.

in: Biopolymer Membranes and Films, Health, Food, Environment, and Energy Applications, Mariana Agostini de Moraes,Classius Ferreira da Silva,Rodrigo Silveira Vieira, Editor, Elsevier Science, Oxford/Amsterdam , Chennai, pp.195-217, 2020

2019

13. Phytosomes as Novel Carriers of Herbal Extracts

Güngör S., Akbal Dağıstan Ö., Algın Yapar E., Kartal M., Erginer Y.

in: Novel Drug Delivery Systems for Phytoconstituents, Gupta M,Chauhan D.A.,Sharma V,Chauhan N.S., Editor, Crc Press, Florida, pp.69-81, 2019

2019

14. Polymeric micelles as a novel carrier for ocular drug delivery

Özsoy Y., Güngör S., Kahraman E., Durgun M. E.

in: Nanoarchitectonics in Biomedicine, Grumezescu AM, Editor, William Andrew Publishing , New York, pp.85-117, 2019

2019

15. Polymeric micelles as a novel carrier for ocular drug delivery

Erginer Y.

in: Nanoarchitectonics in Biomedicine, Alexandru Mihai Grumezescu, Editor, Elsevier Science, Oxford/Amsterdam , New-York, pp.85-117, 2019

2017

16. EczÇEP-Eczacılık Fakülteleri Müfredat Detay Çalışması

Akalın E., Akev N., Erginer Y., Güzeldemirci N., Toker S., Kolak U., et al.

Kapitta Yayıncılık, Ankara, 2017

2017

17. EczÇEP- Eczacılık Fakülteleri Müfredat Detay Çalışması

Akalın Uruşak E., Akev N., Erginer Y., Güzeldemirci N., Toker S., Kolak U., et al.

Kapitta Yayıncılık, Ankara, 2017

2016

18. Dermal and Transdermal Drug Delivery Systems

GÜNGÖR S., ERDAL M. S., ERGİNER Y.

in: Encyclopedia of Biomedical Polymers and Polymeric Biomaterials, Munmaya KM., Editor, Taylor And Francis, New York, pp.2606-2619, 2016

2015

19. Polymeric micelles for cutaneous drug delivery

GÜNGÖR S., KAHRAMAN E., ERGİNER Y.

in: Nano Based Drug Delivery, Naik J., Editor, Iapc Publishing, Zagreb, pp.369-384, 2015

2014

20. Nanotaşıyıcıların aşı uygulamasında kullanılması

ERGİNER Y.

in: Nanofarmasötikler ve Uygulamaları, Zırh Gürsoy A., Editor, ), Aktif Matbaa Ve Reklam Hizm.San.Tic. Ltd.,, İstanbul, pp.283-0, 2014

2014

21. Miseller

ERGİNER Y.

in: Nanofarmasötikler ve Uygulamaları, Zırh Gürsoy A., Editor, Aktif Matbaa Ve Reklam Hizm.San.Tic. Ltd.,, İstanbul, pp.111-123, 2014

2014

22. Nanopartiküllerin gen tedavisinde kullanılması

ERGİNER Y.

in: Nanofarmasötikler ve Uygulamaları, Zırh Gürsoy A., Editor, Aktif Matbaa Ve Reklam Hizm.San.Tic. Ltd, İstanbul, pp.267-277, 2014

2012

23. Plasticizers in Transdermal Delivery Systems

GÜNGÖR S., ERDAL M. S., ERGİNER Y.

in: Plasticizers, Luqman M., Editor, Intech, Rijeka, pp.91-112, 2012

2012

24. Polymeric nanoparticles applied via nasal route.

ERGİNER Y., YILDIZ PEKÖZ A., GÜNGÖR S.

in: Polymeric nanoparticles applied via nasal route., Şenyiğit T., Özcan İ., Özer Ö, Editor, Nanotechnology İn Progress: Pharmaceutical Applications,, Research Signpoint, Kerala, India, Chapter, pp.95-109, 2012

2011

25. Novel formulation approaches for topical and transdermal delivery of non-steroidal antiinflammatory drugs

OKYAR A., ERGİNER Y., GÜNGÖR S.

in: Rheumatoid Arthritis– Treatment, Lemmey A., Editor, Intech, Rijeka, pp.25-48, 2011

2008

26. Particulate Carriers for Nasal Administration

ERGİNER Y.

in: Handbook of Particulate Drug Delivery Vol.2: Applications, KUMAR MNR, Editor, American Scientific Publishers , California, pp.143-164, 2008

2004

27. Veteriner tedavideki dozaj şekilleri

ERGİNER Y.

in: Kontrollü Salım Sistemleri Derneği, Gürsoy A.Z., Editor, Piksel Bilişim Matbaacılık Ve Filmcilik Hizmetleri Ltd. Şti., İstanbul, pp.233-244, 2004

2004

28. Göz, Kulak ve Buruna Uygulanan Dozaj Şekilleri

ERGİNER Y.

in: Farmasötik Teknoloji –Temel Konular ve Dozaj Şekilleri-, ZIRH GÜRSOY A., Editor, Piksel Bilişim Matbaacılık Ve Filmcilik Hizmetleri Ltd. Şti.,, İstanbul, pp.233-244, 2004

2002

29. Kontrollü Salım Sistemlerinin Veteriner Tedavide Kullanımı

ERGİNER Y., ARAMAN A. O.

in: Kontrollü Salım Sistemleri, ZIRH GÜRSOY A., Editor, Elma Bilgisayar Basım Ve Ambalaj San. Tic. Ltd. Şti, İstanbul, pp.371-382, 2002

2000

30. Farmasötik Teknoloji ve Kozmetoloji Laboratuvar Kitabı

Alpmen G., Altınkurt T., Bergişadi N., Topaloğlu Y., Tuncel T., ARAMAN A. O., et al.

Ab Ofset, İstanbul, 2000

1990

31. THE PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF DEFIBROTIDE - A NEW PROFIBRINOLYTIC, ANTITHROMBOTIC AND ANTIPLATETLET SUBSTANCE

ERGİNER Y.

in: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, LIU CY, CHIEN S., Editor, Acad Sınıca; Natl Scı Councıl, Dept Hlth; Fdn Bıomed Scı, Taipei, pp.429-438, 1990

Episodes in the Encyclopedia

2015

1. Encyclopedia of Biomedical Polymers and Polymer Biomaterials

Erdal M. S., Güngör S., Erginer Y.

Taylor And The Francis Press, pp.2606-2619, 2015

Other Publications

2016

1. ALFUZOSİN'İN UZATILMIŞ SALIMLI TABLET FORMÜLASYONU TR İNCELEMESİZ PATENT NO: TR 2012/06229

MESUT B., ERGİNER Y., Aksu B., ARAMAN A. O.

Other, pp.15, 2016

2016

2. KETİAPİN’İN UZATILMIŞ SALIMLI TABLET FORMÜLASYONU TR PATENT BAŞVURUSU NO:TR 2013-G-316804

ERGİNER Y., Özçelik E., MESUT B., Aksu B., ARAMAN A. O.

Other, pp.11, 2016

2015

3. Nişasta esaslı biyo yapışabilen polimerlerin sentezi ve ilaç taşıyıcı sistemlerde uygulamaları, TR PATENTİ No: TR 2012 03191

PABUCCUOĞLU S. K., GÖK M. K., DEMİR K., Cirit Ü., CEVHER E., ERGİNER Y., et al.

Other, pp.20, 2015

Funded Projects

2019 - 2026

ORAL, PARENTERAL, DERMAL VE OFTALMİK UYGULANMAK ÜZERE NANOTEKNOLOJİK YÖNTEMLERLE İLAÇLARIN BİYOYARARLANIMLARININ ARTTIRILMASI AMACIYLA FORMÜLASYONLARIN GELİŞTİRİLMESİ, KARAKTERİZASYONU VE ENDÜSTRİYEL UYGULAMALARI

TUBITAK Project , 2244 - Industrial Phd. Program Project

Erginer Y. (Executive)

2023 - 2024

ANTİFUNGAL ETKEN MADDE İÇEREN NANOSİSTEMLİ TOPİKAL FORMÜLASYONUN HAZIRLANMASI VE İN VİTRO KARAKTERİZASYONU

Project Supported by Higher Education Institutions , BAP Other

ERGİNER Y. (Executive), OPÇİN Ş. N.

2022 - 2024

DÜŞÜK ÇÖZÜNÜRLÜKLÜ İLAÇLARIN SUDAKİ ÇÖZÜNÜRLÜKLERİNİ ARTIRMAYA YÖNELİK NANOLİFLERİNİN HAZIRLANMASI VE KAREKTERİZASYONU

Project Supported by Higher Education Institutions , BAP MSc

ERGİNER Y. (Executive), KARAMÜRSEL E.

2021 - 2024

NANOKRİSTAL TEKNOLOJİSİ İLE ÇÖZÜNÜRLÜĞÜ DÜŞÜK ETKEN MADDELERİN ORAL BİYOYARARLANIMLARININ ARTTIRILMASINA YÖNELİK ÇALIŞMALAR

Project Supported by Higher Education Institutions , BAP PhD

ERGİNER Y. (Executive), PİRİNÇCİ TOK Y.

2021 - 2023

İstanbul Üniversitesi Araştırma Laboratuvarlarının Sürekliliği ve Geliştirilmesi

Project Supported by Higher Education Institutions , BAP Guided

EROL A. (Executive), ÖZHAN G., ULUTAŞ D., KURUOĞLU F., SOLAKOĞLU S., AKÇAALAN ALBAY R., et al.

2020 - 2022

Oküler Uygulamaya Yönelik Posakonazol Yüklü Miseler InSitu Jelleşen Sistemlerin Geliştirilmesi Karakterizasyonu In Vitro ve Ex Vivo ile Değerlendirilmesi

Project Supported by Higher Education Institutions , BAP Research Project

ERGİNER Y. (Executive), DURGUN KILIÇ M. E.

2021 - 2021

Alzheimer Hastalığında Etkili Nazal Yoldan Uygulanabilen Hedeflendirilmiş İnsülin Kuantum Noktası Kompleksinin Geliştirilmesi

Project Supported by Higher Education Institutions , BAP PhD

ERGİNER Y. (Executive), DEĞİM İ. T., ÇAMLIK G.

2019 - 2021

Çözünürlüğü düşük etkin maddenin kendiliğinden emülsifiye olan yeni formülasyonlarının geliştirilmesi, in vitro ve in vivo olarak değerlendirilmesi

Project Supported by Higher Education Institutions , BAP Research Project

ERGİNER Y. (Executive), NAZLI H., ÖZTÜRK D., MESUT B., OKYAR A.

2018 - 2020

Yapay Zeka Teknolojisi Kullanarak Tasarım ile Kalite Yaklaşımı Çerçevesinde Melatonin İçeren Ağızda Dağılan Tablet ODT Formülasyonun Geliştirilmesi In vitro ve Sitotoksisite Analizleri

Project Supported by Higher Education Institutions , BAP Research Project

DEMİRALP B. (Executive), ERGİNER Y., YETİLMEZSOY K., TEKARSLAN ŞAHİN Ş. H.

2018 - 2020

Vitamin D ve PRP İçeren Biyouyumlu Taşıyıcıların Sıçan Kalvaryasında Oluşturulan Kemik Defektleri Üzerine Etkilerinin Araştırılması

Project Supported by Higher Education Institutions , BAP Research Project

(Project Abstract) (Project Final Report)

YALTIRIK M. (Executive), AHISHALI B., TURGUT C. T., ÖZTÜRK D., OKYAR A., GÜNGÖR S., et al.

2018 - 2020

SÜT SIĞIRLARINDA GÖRÜLEN MASTİT HASTALIĞININ ENGELLENMESİ AMACIYLA OLUŞTURULACAK YENİLİKÇİ KOLOFON VE TEREBENTİN İÇEREN DOZAJ FORMLARININ İN-VİTRO VE İN-VİVO DEĞERLENDİRİLMESİİ

Project Supported by Higher Education Institutions , BAP PhD

ERGİNER Y. (Executive), ABAŞ İ., TEKDEMİR O.

2016 - 2020

Prostat kanseri tedavisi için yeni nesil sentetik ajanların geliştirilmesi

TUBITAK Project , 1003 - Priority Areas R&D Projects Support Program

Erginer Y., Cevher E., Ertürk E.(Executive)

2017 - 2019

Aprepitant etkin maddesini içeren kendiliğinden emülsifiye olabilen sistemlerin SMEDD hazırlanması ve in vitro karakterizasyonunun değerlendirilmesi

Project Supported by Higher Education Institutions , BAP Research Project

ERGİNER Y. (Executive), MESUT B., TEKARSLAN Ş. H.

2016 - 2019

OKÜLER UYGULAMAYA YÖNELİK NANOTAŞIYICILARIN HAZIRLANMASI

Project Supported by Higher Education Institutions , BAP PhD

ERGİNER Y. (Executive), DURGUN M. E.

2017 - 2018

Biyoindirgenebilir Nanopartiküler Taşıyıcı Sistemlerin Sentezi ve Optimizasyonu

Project Supported by Higher Education Institutions , BAP Other

GÖK M. K. (Executive), ERGİNER Y., PABUCCUOĞLU S. K., PABUCCUOĞLU S., DEMİR K.

2017 - 2018

Skin Penetration Enhancement Mechanism of Mixed Micelles

Project Supported by Higher Education Institutions , BAP Other

KAHRAMAN ŞİRİN E. (Executive), ERGİNER Y., GÜNGÖR S.

2017 - 2018

Mikroemülsiyon tipi kolloidal taşıyıcı sistemlerin antifungal aktivitelerinin tayin edilmesi

Project Supported by Higher Education Institutions , BAP Other

ERDAL M. S. (Executive), ERGİNER Y., GÜNGÖR S., MAT C.

2017 - 2018

Penetration EnhancerContaining Nanomicelles for Topical Delivery Impact on Skin Barrier

Project Supported by Higher Education Institutions , BAP Other

ERGİNER Y. (Executive), KAHRAMAN E., GÜNGÖR S.

2017 - 2018

Sentetik Çift Tabakalı Hidroksitlerin (LDH) Fonksiyonelleştirilmesi Üzerine Optimizasyon Çalışmaları

Project Supported by Higher Education Institutions , BAP Other

PABUCCUOĞLU S. K. (Executive), GÖK M. K., DEMİR K., ERGİNER Y., KANTÜRK FİGEN A., PABUCCUOĞLU S., et al.

2017 - 2018

DİYABET TEDAVİSİ İÇİN SABİT DOZ KOMBİNASYONLU TABLET FORMÜLASYONUNUN GELİŞTİRİLMESİ

Project Supported by Higher Education Institutions , BAP Other

ERGİNER Y. (Executive), GÜNGÖR S.

2015 - 2017

PEG-DSPE Miseller Taşıyıcıların Topikal Yol ile Değerlendirilmesi

Project Supported by Higher Education Institutions , BAP Other

ERGİNER Y. (Executive)

2014 - 2017

Topikal Uygulamaya Yönelik Polimerik Misel Sistemlerinin Geliştirilmesi

Project Supported by Higher Education Institutions , BAP PhD

ERGİNER Y. (Executive), KAHRAMAN E.

2014 - 2017

Ölçek Büyütmeye Uygun Nanoemülsiyon Formülasyonunun QbD ile Tasarımı ve Yapay Sinir Ağları ile Optimizasyonu

Project Supported by Higher Education Institutions , BAP PhD

ERGİNER Y. (Executive), MESUT B.

2010 - 2017

Nişasta Esaslı Biyoadesif Polimerlerin Sentezi ve İlaç Taşıyıcı Sistemlerde Kullanımı

Project Supported by Higher Education Institutions , BAP Research Project

PABUCCUOĞLU S. K. (Executive), BACINOĞLU S., GÖK M. K., PABUCCUOĞLU S., CEVHER E., ERGİNER Y., et al.

2016 - 2016

A NOVEL BIODEGRADABLE TABLET FOR SHORTTERM TREATMENT VIA VAGINAL ROUTE IN VETERINARY MEDICINE

Project Supported by Higher Education Institutions , BAP Other

PABUCCUOĞLU S. K. (Executive), BACINOĞLU S., CİRİT Ü., DEMİR K., GÖK M. K., CEVHER E., et al.

2015 - 2016

Formulation design and optimisation of the oral disintegrating tablet contains Alfuzosin hydrochloride via Quality by Design Approach

Project Supported by Higher Education Institutions , BAP Other

ERGİNER Y. (Executive)

2014 - 2016

OKÜLER UYGULAMAYA YÖNELİK TAKROLİMUS YÜKLÜ PLURONİK MİSELLERİN HAZIRLANMASI

Project Supported by Higher Education Institutions , BAP Research Project

ERGİNER Y. (Executive), GÜNGÖR S., KAHRAMAN E.

2013 - 2016

İstanbul Üniversitesi Bilimsel Araştırmalarının Patentlenmesi

Project Supported by Higher Education Institutions , BAP Guided

YARMAN B. S. B. (Executive), TERZİ E., GÖK M. K., PABUCCUOĞLU S. K., PABUCCUOĞLU S., SİLME R. S., et al.

2015 - 2015

Ağızda Dağılan Tabletlerin Tasarımda Kalite (QbD) ile Optimizasyonu

Project Supported by Higher Education Institutions , BAP Other

ERGİNER Y. (Executive)

2014 - 2015

TOPİKAL NANO TAŞIYISI SİSTEMLERİN OPTİMİZASYONU VE KARAKTERİZYONU

Project Supported by Higher Education Institutions , BAP Other

ERGİNER Y. (Executive)

2014 - 2014

BENZOİL PEROKSİT YÜKLÜ MİKROSÜNGER TAŞIYICI SİSTEMLİ TOPİKAL FORMÜLASYONLARIN İN VİTRO PERFORMANS TESTLERİ İLE DERİ ÜZERİNDEKİ ETKİNLİKLERİNİN DEĞERLENDİRİLMESİ

Project Supported by Higher Education Institutions , BAP Other

ERGİNER Y. (Executive)

2012 - 2014

Ketiapin Fumarat Etkin Maddesini İçeren Uzatılmış Salımlı Tablet Formülasyonlarının Yapay Sinir Ağları İle Tasarımı

Project Supported by Higher Education Institutions , BAP PhD

ERGİNER Y. (Executive)

2011 - 2014

NANOPARTİKÜL MÜHENDİSLİĞİ İLE ETKİN AŞI TAŞIYICI SİSTEMLERİN GELİŞTİRİLMESİ: HAZIRLANMASI, KARAKTERİZASYONU VE HÜCRE KÜLTÜRÜ ÇALIŞMALARI

Project Supported by Higher Education Institutions , BAP Research Project

ERGİNER Y. (Executive)

2011 - 2014

Boğaziçi Üniversitesi Yaşam Bilimleri ve Teknolojileri Merkezi- Nanoteknolojik yöntemlerle ilaç yüklü partiküllerin hazırlanması

CB Strateji ve Bütçe Başkanlığı (Kalkınma Bakanlığı) Projesi

ERGİNER Y.

2012 - 2013

ONDANSETRON?UN DOĞAL POLİMERLER İLE TRANSDERMAL FİLMLERİNİN HAZIRLANMASI VE PERKÜTAN ABSORPSİYONU ÜZERİNE TERPENLERİN ETKİLERİNİN DEĞERLENDİRİLMESİ

Project Supported by Higher Education Institutions , BAP Other

ERGİNER Y. (Executive)

2010 - 2011

Misel Oluşturan, Biyobozunur, Biyouyumlu, Katyonik Polimerler ile İlaçların Nazal Yol ile Uygulanması

Project Supported by Higher Education Institutions , BAP MSc

ERGİNER Y. (Executive)

2009 - 2011

Metoklopramit Hidroklorürün Transdermal Formülasyonlarının Optimizasyonu

Project Supported by Higher Education Institutions , BAP Other

ERGİNER Y. (Executive)

2009 - 2011

Radyonüklid tedavi için Lutesyum 177 (Lu-177) işaretli radyopeptidlerin kararlılık çalışmalarının standardizasyonu

TUBITAK Project

ERGİNER Y., OCAK DEMİRCİ E. M.

2009 - 2009

IN VITRO EVAULATION OF NASAL INSERTS OF VERAPAMIL HCL

Project Supported by Higher Education Institutions , BAP Other

ERGİNER Y. (Executive)

2008 - 2008

NAZAL YOLLA UYGULANMAK ÜZERE ONDANSETRON HCL?IN KİTOZAN MİKROKÜRELERİ ÜZERİNDE İN VİTRO VE İN VİVO ÇALIŞMALAR

Project Supported by Higher Education Institutions , BAP Other

ERGİNER Y. (Executive)

Patent

2019

CANNABİDİOLÜN NAZAL UYGULANAN KOLLOİDAL FORMÜLASYONLARI

Patent

Pending / Applied, The Invention Recourse Number: 2019/22178 , Standard Registration

2018

Hint Yağı İçeren Kapsül Formunda Farmasötik Bileşim

Patent

Pending / Applied, The Invention Recourse Number: 2018/20564 , Standard Registration

2016

APREPİTANTIN KENDİLİĞİNDEN EMÜLSİFİYE OLAN SALIM SİSTEMİ İLE HAZIRLANMIŞ KATI DOZAJ FORMÜLASYONU

Patent

Pending / Applied, The Invention Recourse Number: , Standard Registration

2016

APREPİTANT VE DEKSAMETAZONUN KENDİLİĞİNDEN EMÜLSİFİYE OLAN SALIM SİSTEMİ İLE HAZIRLANMIŞ KATI DOZAJ FORMU KOMBİNASYONU

Patent

Pending / Applied, The Invention Recourse Number: , Standard Registration

2016

Alfuzosin'in Uzatılmış Salımlı Tablet Formülasyonu

Patent

Registered / Approved, The Invention Registration Number: 2012 06229 , Standard Registration

2015

Nişasta Esaslı biyoyapışabilen polimerlerin sentezi ve ilaç taşıyıcı sistemlerde uygulamaları

Patent

2014

Extended Release Tablet Formulations of Quetiapine

Patent

Pending / Applied, The Invention Recourse Number:

2013

Ketiapin'in Uzatılmış Salımlı Tablet Formülasyonu

Patent

Pending / Applied, The Invention Recourse Number: , Standard Registration

Activities in Scientific Journals

2016 - Present

Acta Pharmaceutica Sciencia

Committee Member

2012 - Present

Türkiye Klinikleri Eczacılık Bilimleri Dergisi

Advisory Committee Member

2011 - Present

İstanbul Üniversitesi Eczacılık Fakültesi Dergisi

Advisory Committee Member

2010 - 2012

- Mersin Üniversitesi Sağlık Bilimleri Dergisi

Advisory Committee Member

2010 - 2011

- Acta Pharmaceutica Sciencia (Formerly "Acta Pharmaceutica Turcica”),

Assistant Editor/Section Editor

Memberships and Roles in Scientific Organizations

2008 - Present

Controlled Release Society

Member

2007 - Present

EUFEBS

Member

1994 - Present

Farmasötik Bilimler Ankara Derneği (FABAD)

Member

1993 - Present

Türk Farmasötik Teknoloji Araştırmacıları Derneği (TÜFTAD)

Member

1990 - 2019

Tromboz ve Anjioloji Derneği

Member

1987 - 2019

Türk Hematoloji Derneği (THD)

Member

2017 - 2018

SBAG-Grup Yürütme Komisyon Üyeliği

Executive Board Member

Peer Reviews in Scientific Publications

April 2021

LİTERATÜR ECZACILIK BİLİMLERİ DERGİSİ

National Scientific Refreed Journal

March 2021

Journal of Research in Pharmacy

Other Indexed Journal

November 2020

Acta pharmaceutica Sciencia

Other Indexed Journal

May 2020

Turkish Journal of Pharmaceutical Sciences

Other Indexed Journal

April 2019

Acta Pharmaceutica Sciencia

Other Indexed Journal

November 2017

Turkish Journal of Chemistry

Other Indexed Journal

December 2016

Journal of research in pharmacy (online)

Other Indexed Journal

July 2016

Acta Pharmaceutica Sciencia

Other Indexed Journal

June 2015

LİTERATÜR ECZACILIK BİLİMLERİ DERGİSİ

National Scientific Refreed Journal

November 2013

LİTERATÜR ECZACILIK BİLİMLERİ DERGİSİ

National Scientific Refreed Journal

Scientific Project Refereeing

May 2021

TUBITAK Project

1002 - Quick Support Program, Istanbul University, Turkey

March 2021

TUBITAK Project

1002 - Quick Support Program, TÜBİTAK, Turkey

January 2021

Project Supported by Higher Education Institutions

BAP Research Project, Istanbul University, Turkey

December 2020

Project Supported by Higher Education Institutions

BAP Other, Hacettepe University, Turkey

November 2020

TUBITAK Project

1002 - Quick Support Program, TÜBİTAK, Turkey

November 2020

Project Supported by Higher Education Institutions

BAP Research Project, Ege University, Turkey

October 2020

TUBITAK Project

1505 - University-Industry Cooperation Support Program, TÜBİTAK-TEGEM, Turkey

October 2020

Project Supported by Higher Education Institutions

BAP Research Project, Anadolu University, Turkey

October 2020

Research Project of the Presidency of Turkey Health Institutes (TÜSEB)

TÜSEB, Turkey

August 2020

TUBITAK Project

1001 - Program for Supporting Scientific and Technological Research Projects, TÜBİTAK, Turkey

June 2020

TUBITAK Project

2219 - Yurt Dışı Doktora Sonrası Araştırma Burs Programı, Istanbul University, Turkey

June 2020

TUBITAK Project

1001 - Program for Supporting Scientific and Technological Research Projects, Istanbul University, Turkey

February 2020

TUBITAK Project

1002 - Quick Support Program, Istanbul University, Turkey

November 2019

TUBITAK Project

1002 - Quick Support Program, Istanbul University, Turkey

October 2019

Project Supported by Higher Education Institutions

BAP Research Project, Anadolu University, Turkey

September 2019

Project Supported by Higher Education Institutions

BAP Research Project, Istanbul University, Turkey

January 2019

Project Supported by Higher Education Institutions

BAP Research Project, Marmara University, Turkey

January 2019

Project Supported by Higher Education Institutions

BAP Research Project, Anadolu University, Turkey

November 2018

TUBITAK Project

1002 - Quick Support Program, Turkey

April 2018

Project Supported by Higher Education Institutions

BAP Research Project, Altinbas University, Turkey

April 2017

Project Supported by Higher Education Institutions

BAP PhD, Hacettepe University, Turkey

Scientific Consultations

2020 - 2025

Scientific Consultancy

Sağlık Bakanlığı, Türkiye İlaç ve Tıbbi Cihaz Kurumu

Istanbul University, Faculty Of Pharmacy , Department Of Pharmaceutical Technology, Turkey

2016 - 2024

Project Consultancy

KOSGEB

Istanbul University, Faculty Of Pharmacy , Department Of Pharmaceutical Technology, Turkey

2021 - 2021

Other

Türkiye Sağlık Enstitüleri Başkanlığı

Istanbul University, Faculty Of Pharmacy , Department Of Pharmaceutical Technology, Turkey

2010 - 2018